We established a nomogram using the four independent risk factors (gender, tumor number, tumor size and Alb/Glb) screened out by RSF, LASSO and multivariate Cox regression analysis for predicting recurrence after TACE combined with ablation therapy in BCLC A/B HCC patients with Child-Pugh B cirrhosis (Figure 5). The gene discussed is ALB; the disease is neoplasm.